v3.26.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Operating expenses:        
Research and development $ 5,021 $ 4,519 $ 13,978 $ 13,496
General and administrative 2,511 2,206 7,375 7,250
Total operating expenses 7,532 6,725 21,353 20,746
Loss from operations (7,532) (6,725) (21,353) (20,746)
Other income, net 282 195 953 770
Net loss $ (7,250) $ (6,530) $ (20,400) $ (19,976)
Net loss per common share - basic (in dollars per share) $ (0.08) $ (0.11) $ (0.24) $ (0.34)
Net loss per common share - diluted (in dollars per share) $ (0.08) $ (0.11) $ (0.24) $ (0.34)
Weighted average shares outstanding - basic (in shares) 90,119 59,711 86,192 59,399
Weighted average shares outstanding - diluted (in shares) 90,119 59,711 86,192 59,399